Iron metabolism and risk of cancer in the Swedish AMORIS study

Cancer Causes and Control

Volumn 24, Issue 7, 2013, Pages 1393-1402

  Gaur, Anjali ^a   Collins, Helen ^b   Wulaningsih, Wahyu ^a   Holmberg, Lars ^a,c   Garmo, Hans ^a,c   Hammar, Niklas ^d,e   Walldius, Göran ^e   Jungner, Ingmar ^e   Van Hemelrijck, Mieke ^a,e  

^a Department of Rheumatology School of Medicine   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UPPSALA UNIVERSITY   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

C reactive protein; Cancer; Iron; Iron binding capacity; Sweden

Indexed keywords

C REACTIVE PROTEIN; IRON;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON METABOLISM; KIDNEY CANCER; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT CANCER; RISK ASSESSMENT; STOMACH CANCER; SWEDEN;

ADULT; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; IRON; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROSPECTIVE STUDIES; RISK;

EID: 84878936027     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0219-8     Document Type: Article

References (25)

1. Mascitelli L, Goldstein MR (2011) Metabolic syndrome and liver cancer: is excess iron the link? Hepatology 54(4):1487
2. Weinberg ED (1996) The role of iron in cancer. Eur J Cancer Prev 5(1):19-36 (Pubitemid 26049984)
3. Kabat GC, Miller AB, Jain M, Rohan TE (2007) A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women. Br J Cancer [Research Support, Non-US Gov't] 97(1):118-122 (Pubitemid 47012094)
4. Kabat GC, Miller AB, Jain M, Rohan TE (2007) Dietary iron and heme iron intake and risk of breast cancer: A prospective cohort study. Cancer Epidemiol Biomarkers Prev [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't] 16(6):1306-1308 (Pubitemid 46984977)
5. Cross AJ, Sinha R, Wood RJ, Xue X, Huang WY, Yeager M, et al. (2011) Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Prev Res (Phila) 4(9):1465-1475
6. Wu T, Sempos CT, Freudenheim JL, Muti P, Smit E (2004) Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol 14(3):195-201 (Pubitemid 38249333)
7. Li F, Kishida T, Kobayashi M (1999) Serum iron and ferritin levels in patients with colorectal cancer in relation to the size, site, and disease stage of cancer. J Gastroenterol 34(2):195-199 (Pubitemid 29192558)
8. Kooistra MP, Niemantsverdriet EC, van Es A, Mol-Beermann NM, Struyvenberg A, Marx JJ (1998) Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium. Nephrol Dial Transpl 13(1):82-88 (Pubitemid 28033584)
9. Van Hemelrijck M, Holmberg L, Garmo H, Hammar N, Walldius G, Binda E, et al. (2011) Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS study. Cancer Epidemiol Biomarkers Prev 20(3):428-437
10. Rajamaki A, Irjala K, Aitio A (1979) Immunochemical determination of serum transferrin. Reference values, correlation with serum total iron-binding capacity and value in the diagnosis of iron deficiency anaemia and anaemia of chronic disorders. Scandinavian J Haematol 23(3):227-231 (Pubitemid 10197954)
11. Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E (2001) High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): A prospective study. Lancet 358(9298):2026-2033 (Pubitemid 34084825)
12. Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E (1998) Apolipoprotein B and A-I values in 147576 Swedish males and females, standardized according to the world health organization-international federation of clinical chemistry first international reference materials. Clin Chem 44(8 Pt 1):1641-1649 (Pubitemid 28381205)
13. Holme I, Aastveit AH, Jungner I, Walldius G (2008) Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the apolipoprotein mortality risk study (AMORIS). J Intern Med 264(1):30-38 (Pubitemid 351813479)
14. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009) Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the apolipoprotein mortality risk study (AMORIS). J Intern Med 265(2):275-287
15. Walldius G, Jungner I, Kolar W, Holme I, Steiner E (1992) High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related mortality risk) study. Blood Press Suppl 4:35-42
16. Van Hemelrijck M, Garmo H, Binda E, Hayday A, Karagiannis SN, Hammar N, et al. (2010) Immunoglobulin E and cancer: A meta-analysis and a large Swedish cohort study. Cancer Causes Control 21:1657-1667
17. Van Hemelrijck M, Garmo H, Holmberg L, Walldius G, Jungner I, Hammar N, Lambe M (2011) Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose. Cancer 117(10):2086-2095
18. Central Bureau for Statistics. Statistics Sweden. Stockholm SAfhwss
19. Wilkins J, Gallimore JR, Moore EG, Pepys MB (1998) Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem 44(6 Pt 1):1358-1361 (Pubitemid 28283085)
20. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dagg K, Scott HR (2005) A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 92(10):1834-1836 (Pubitemid 40826128)
21. Proctor MJ, Talwar D, Balmar SM, O'Reilly DS, Foulis AK, Horgan PG, et al. (2010) The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow inflammation outcome study. Br J Cancer 103(6):870-876
22. Bengtsson C, Lindquist O, Redvall L (1981) Menstrual status and menopausal age of middle-aged Swedish women. A population study of women in Goteborg 1968-1969 and 1974-1975. Acta Obstet Gynecol Scand 60(3):269-275 (Pubitemid 11078839)
23. Lambe M, Wigertz A, Garmo H, Walldius G, Jungner I, Hammar N (2011) Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer. Cancer Causes Control 22(8):1163-1171
24. Holzmann M, Jungner I, Walldius G, Ivert I, Nordqvist T, Östergren J (2008) Apolipoproteins B and A-I, standard lipid measures and incidence of myocardial infarction in men and women, with or without chronic kidney disease. Study IV in thesis for doctorial degree (Ph.D.). In: Holzmann M (ed) Renal insufficiency, mortality and myocardial infarction, Stockholm, Karolinska Institutet
25. Vanarsa K, Ye Y, Han J, Xie C, Mohan C, Wu T (2012) Inflammation associated anemia and ferritin as disease markers in SLE. Arthritis Res Ther 14(4):R182